Oncology Brothers: 14 new drugs/indications in Lung Cancer by FDA in 2024
Oncology Brothers posted on X:
“2024 approvals: Summary of 14 new drugs/indications in Lung Cancer by FDA:
1. Tepotinib
2. Osimertinib x2
3. Alectinib
4. Tarlatamab
5. Zenocutuzumab
6. Durvalumab x2
7. Amivantamab x2
8. Nivolumab
9. Ensartinib.”
Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families. Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023